Insecticides (India) Ltd FY26 Results

Insecticides (India) Limited reported FY26 consolidated revenue of ₹2,140.01 crore, a 7% increase year-on-year. The company's Profit After Tax (PAT) saw a 2% decline to ₹139.41 crore for the same period.

Reader Takeaway: Revenue growth driven by premium products; minor PAT dip due to margin pressure.

What just happened

Insecticides (India) Limited announced its consolidated financial results for the fiscal year ended March 2026 (FY26). The company recorded revenues from operations at ₹2,140.01 crore, up 7% from ₹1,999.95 crore in FY25. EBITDA grew by 3% to ₹227.05 crore. However, Profit After Tax (PAT) decreased by 2% to ₹139.41 crore from ₹142.02 crore in the previous year. Earnings Per Share (EPS) was ₹47.91 compared to ₹48.38 in FY25.

Why this matters

The 7% revenue growth indicates sustained demand for the company's products. The increase in the share of premium products in the B2C segment to 58% suggests a successful strategy towards higher-value offerings. Improved working capital management, with net working capital days reduced to 168 from 172, points to better operational efficiency and cash flow.

The backstory

Insecticides (India) Limited is a significant player in the agrochemical sector, focusing on crop protection chemicals. The company has been emphasizing a strategy of premiumization and integrated manufacturing to drive growth and improve margins. Its distribution network is extensive, reaching a large base of farmers and retailers.

What changes now

The results show a company navigating a challenging margin environment while expanding its top line. The focus on premiumization is a key strategic shift that could drive future profitability if margins can be sustained. Improved working capital efficiency is a positive operational development.

Risks to watch

The primary concern highlighted is the 2% decline in Profit After Tax despite revenue growth. This suggests potential pressure on margins due to increased costs or competitive pricing. Investors will need to monitor if the company can translate its revenue growth and premiumization strategy into improved profitability in the coming periods.

Peer comparison

While specific peer data for FY26 is not provided in the filing, the agrochemical sector typically faces challenges related to raw material costs, monsoon dependency, and regulatory changes. Companies often focus on R&D and product innovation to maintain competitive advantage and pricing power.

Context metrics (time-bound)

• FY26 Consolidated Revenue: ₹2,140.01 Cr (up 7% Y-o-Y)
• FY26 Consolidated EBITDA: ₹227.05 Cr (up 3% Y-o-Y)
• FY26 Consolidated PAT: ₹139.41 Cr (down 2% Y-o-Y)
• FY26 B2C Premium Product Share: 58%
• FY26 Net Working Capital Days: 168 days (down from 172 days in FY25)

What to track next

Investors will be looking for updates on the company's ability to maintain its revenue momentum, particularly from premium products. Monitoring margin trends and the impact of any cost pressures will be crucial. Further progress in working capital management and the overall market conditions for agrochemicals will also be key factors.